494 related articles for article (PubMed ID: 17889119)
21. Impact of continuous value of body mass index on graft loss in overweight patients.
Papalia T; Greco R; Lofaro D; Maestripieri S; Mancuso D; Bonofiglio R
Transplant Proc; 2010 May; 42(4):1074-6. PubMed ID: 20534226
[TBL] [Abstract][Full Text] [Related]
22. [Post-transplant nephropathy and arterial hypertension].
Oko A; Idasiak-Piechocka I; Czekalski S
Przegl Lek; 2001; 58(9):859-63. PubMed ID: 11868248
[TBL] [Abstract][Full Text] [Related]
23. High body mass index and posttransplant weight gain are not risk factors for kidney graft and patient outcome.
Marcén R; Fernández A; Pascual J; Teruel JL; Villafruela JJ; Rodriguez N; Martins J; Burgos FJ; Ortuño J
Transplant Proc; 2007 Sep; 39(7):2205-7. PubMed ID: 17889138
[TBL] [Abstract][Full Text] [Related]
24. Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction.
Ruiz JC; Campistol JM; Sánchez-Fructuoso A; Rivera C; Oliver J; Ramos D; Campos B; Arias M; Diekmann F
Nephrol Dial Transplant; 2006 Nov; 21(11):3252-7. PubMed ID: 16954170
[TBL] [Abstract][Full Text] [Related]
25. Impact of chronic allograft nephropathy and subsequent modifications of immunosuppressive therapy on late graft outcomes in renal transplantation.
Montagnino G; Banfi G; Campise MR; Passerini P; Aroldi A; Cesana BM; Ponticelli C
Nephrol Dial Transplant; 2004 Oct; 19(10):2622-9. PubMed ID: 15316096
[TBL] [Abstract][Full Text] [Related]
26. Factors affecting kidney-transplant outcome in recipients with lupus nephritis.
Tang H; Chelamcharla M; Baird BC; Shihab FS; Koford JK; Goldfarb-Rumyantzev AS
Clin Transplant; 2008; 22(3):263-72. PubMed ID: 18482047
[TBL] [Abstract][Full Text] [Related]
27. [Systemic hypertension after kidney transplantation: associated risk factors and influence on graft survival].
Chew-Wong A; Alberú-Gómez J; Abasta-Jiménez M; Márquez-Díaz F; Correa-Rotter R
Gac Med Mex; 2005; 141(6):461-7. PubMed ID: 16381499
[TBL] [Abstract][Full Text] [Related]
28. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
29. [Changing profiles of proteinuria in renal transplantation. Predictive factors for its appearance].
Jiménez del Cerro LA; Franco A; Olivares J
Nefrologia; 2002; 22(4):356-63. PubMed ID: 12369127
[TBL] [Abstract][Full Text] [Related]
30. Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients.
van Ree RM; de Vries AP; Oterdoom LH; The TH; Gansevoort RT; Homan van der Heide JJ; van Son WJ; Ploeg RJ; de Jong PE; Gans RO; Bakker SJ
Nephrol Dial Transplant; 2005 Nov; 20(11):2524-31. PubMed ID: 16115856
[TBL] [Abstract][Full Text] [Related]
31. Immunosuppression with antithymocyte globulin in renal transplantation: better long-term graft survival.
Martins L; Fonseca I; Almeida M; Henriques AC; Dias L; Sarmento AM; Cabrita A
Transplant Proc; 2005; 37(6):2755-8. PubMed ID: 16182802
[TBL] [Abstract][Full Text] [Related]
32. Proteinuria in kidney transplant recipients: prevalence, prognosis, and evidence-based management.
Knoll GA
Am J Kidney Dis; 2009 Dec; 54(6):1131-44. PubMed ID: 19726115
[TBL] [Abstract][Full Text] [Related]
33. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
[TBL] [Abstract][Full Text] [Related]
34. Pretransplant and early posttransplant predictors of chronic allograft nephropathy in cadaveric kidney allograft--a single-center analysis of 1112 cases.
Lietz K; Lewandowski Z; Lao M; Paczek L; Gaciong Z
Transpl Int; 2004 Feb; 17(2):78-88. PubMed ID: 14605803
[TBL] [Abstract][Full Text] [Related]
35. ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial.
Paoletti E; Cassottana P; Amidone M; Gherzi M; Rolla D; Cannella G
Am J Kidney Dis; 2007 Jul; 50(1):133-42. PubMed ID: 17591533
[TBL] [Abstract][Full Text] [Related]
36. Pretransplantation systolic blood pressure and the risk of delayed graft function in young living-related renal allograft recipients.
Ozdemir FN; Ibis A; Altunoglu A; Usluogullari A; Arat Z; Haberal M
Transplant Proc; 2007 May; 39(4):842-5. PubMed ID: 17524827
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors associated with poor graft outcomes in renal recipients with post-transplant glomerulonephritis.
Requião-Moura LR; Moscoso-Solorzano GT; Franco MF; Ozaki KS; Pacheco-Silva A; Kirsztajn GM; Câmara NO
Clin Transplant; 2007; 21(3):363-70. PubMed ID: 17488386
[TBL] [Abstract][Full Text] [Related]
38. Reduced graft function (with or without dialysis) vs immediate graft function--a comparison of long-term renal allograft survival.
Johnston O; O'kelly P; Spencer S; Donohoe J; Walshe JJ; Little DM; Hickey D; Conlon PJ
Nephrol Dial Transplant; 2006 Aug; 21(8):2270-4. PubMed ID: 16720598
[TBL] [Abstract][Full Text] [Related]
39. Chronic allograft nephropathy and nephrotic range proteinuria.
Ramanathan V; Suki WN; Rosen D; Truong LD
Clin Transplant; 2005 Jun; 19(3):413-7. PubMed ID: 15877807
[TBL] [Abstract][Full Text] [Related]
40. Pretransplantation and posttransplantation body mass indices and prognosis in renal transplant recipients: low versus normal.
Sezer S; Ozdemir FN; Elsurer R; Uyar M; Arat Z; Haberal M
Transplant Proc; 2005 Sep; 37(7):2994-7. PubMed ID: 16213283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
